Researchers from Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center presented new data demonstrating the efficacy of Clorox Healthcare® Fuzion™ Cleaner Disinfectant at IDWeek 2017™. The study showed that Clorox Healthcare® Fuzion™ Cleaner Disinfectant was as effective for killing Clostridium difficile (C. difficile) spores, methicillin-resistant Staphylococcus aureus, and carbapenem-resistant Escherichia coli as a standard bleach product, but was less damaging to surfaces and left less residue on surfaces.(1)
Both bleach formulations reduced each of the pathogens by ≥6.0 log10CFU with a 2-minute contact time. An assessment of real-world materials compatibility of the products by repeated spray applications on a hospital mattress, Formica bedside table, and textiles, found that Fuzion caused minimal to no adverse effects with up to 60 applications. Personnel using the products also reported that Fuzion left much less residue after use and was more tolerable than the standard bleach product.
The research team led by Curtis J. Donskey, MD, professor of medicine at Case Western Reserve University and Infectious Disease Physician at the Louis Stokes Cleveland VA Medical Center, presented the findings as a poster abstract on Oct. 5, 2017 at the IDWeek conference in San Diego.
“Contaminated surfaces are a potential source for dissemination of pathogens in the healthcare environment,” said Donskey. “Our results confirm the product’s efficacy against clinically relevant healthcare pathogens and suggest that Fuzion may provide an alternative sporicidal disinfectant for facilities concerned about surface compatibility.”
Fuzion is the next generation of bleach and the first product of its kind to combine trusted bleach efficacy against tough-to-kill pathogens with the aesthetics required for broad use throughout healthcare facilities. Fuzion is Environmental Protection Agency (EPA)-registered to kill C. difficile spores in two minutes, the fastest kill time available,(2) and 35 other pathogens in one minute.
References:
1. Mana, T.S.; Cadnum, J.L.; Piedrahita, C.; Jencson, A.L.; Donskey, C.J. An equally effective but better tolerated formulation of bleach. Poster session presented at: IDWeek 2017 Oct. 4-8; San Diego, CA.
2. Based on EPA Master Label Comparison as of 4/19/2016.
Source: Clorox Healthcare
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.